These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 16216956)

  • 1. Pallidal vs subthalamic deep brain stimulation for Parkinson disease: winner and loser or a sharing of honors?
    Minguez-Castellanos A; Escamilla-Sevilla F
    Arch Neurol; 2005 Oct; 62(10):1642-3; author reply 1643. PubMed ID: 16216956
    [No Abstract]   [Full Text] [Related]  

  • 2. Subthalamic nucleus vs globus pallidus interna deep brain stimulation, the rematch: will pallidal deep brain stimulation make a triumphant return?
    Okun MS; Foote KD
    Arch Neurol; 2005 Apr; 62(4):533-6. PubMed ID: 15824249
    [No Abstract]   [Full Text] [Related]  

  • 3. Multisite randomized trial of deep brain stimulation.
    Follett K; Weaver F; Stern M; Marks W; Hogarth P; Holloway K; Bronstein J; Duda J; Horn S; Lai E; Samii A
    Arch Neurol; 2005 Oct; 62(10):1643-4; author reply 1644-5. PubMed ID: 16216957
    [No Abstract]   [Full Text] [Related]  

  • 4. Pallidal vs subthalamic deep brain stimulation for Parkinson disease.
    Komotar RJ; Starke RM; Connolly ES; Goodman RR
    Neurosurgery; 2010 Oct; 67(4):N25-7. PubMed ID: 20881548
    [No Abstract]   [Full Text] [Related]  

  • 5. Role of surgery in the treatment of motor complications.
    Metman LV; O'Leary ST
    Mov Disord; 2005; 20 Suppl 11():S45-56. PubMed ID: 15822076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-frequency stimulation of the subthalamic nucleus increases pallidal neuronal firing rate in a patient with Parkinson's disease.
    Reese R; Steigerwald F; Pötter M; Herzog J; Deuschl G; Volkmann J; Pinsker MO; Mehdorn HM
    Mov Disord; 2008 Oct; 23(13):1945-7. PubMed ID: 18661546
    [No Abstract]   [Full Text] [Related]  

  • 7. Deep-brain stimulation for Parkinson's disease.
    Okun MS
    N Engl J Med; 2012 Oct; 367(16):1529-38. PubMed ID: 23075179
    [No Abstract]   [Full Text] [Related]  

  • 8. Eyelid apraxia associated with subthalamic nucleus deep brain stimulation.
    Shields DC; Lam S; Gorgulho A; Emerson J; Krahl SE; Malkasian D; DeSalles AA
    Neurology; 2006 May; 66(9):1451-2. PubMed ID: 16682687
    [No Abstract]   [Full Text] [Related]  

  • 9. Levodopa response in long-term bilateral subthalamic stimulation for Parkinson's disease.
    Piboolnurak P; Lang AE; Lozano AM; Miyasaki JM; Saint-Cyr JA; Poon YY; Hutchison WD; Dostrovsky JO; Moro E
    Mov Disord; 2007 May; 22(7):990-7. PubMed ID: 17443692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Deep brain stimulation for Parkinson's disease].
    Date I; Matsui T
    No To Shinkei; 2004 Oct; 56(10):827-41. PubMed ID: 15609670
    [No Abstract]   [Full Text] [Related]  

  • 11. On-period unified Parkinson's disease rating scale before surgery correlates with differences in outcomes between pallidal and subthalamic stimulation: a meta-analysis.
    Sako W; Murakami N; Miyazaki Y; Izumi Y; Kaji R
    Neurol Sci; 2016 Jan; 37(1):135-137. PubMed ID: 26335017
    [No Abstract]   [Full Text] [Related]  

  • 12. Long-term effects of deep brain stimulation in Parkinson's disease.
    Freund HJ
    Brain; 2005 Oct; 128(Pt 10):2222-3. PubMed ID: 16183664
    [No Abstract]   [Full Text] [Related]  

  • 13. Apraxia of eyelid opening after subthalamic deep brain stimulation may be caused by reduction of levodopa.
    Umemura A; Toyoda T; Yamamoto K; Oka Y; Ishii F; Yamada K
    Parkinsonism Relat Disord; 2008 Dec; 14(8):655-7. PubMed ID: 18316231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. End of day dyskinesia in advanced Parkinson's disease can be eliminated by bilateral subthalamic nucleus or globus pallidus deep brain stimulation.
    Apetauerova D; Ryan RK; Ro SI; Arle J; Shils J; Papavassiliou E; Tarsy D
    Mov Disord; 2006 Aug; 21(8):1277-9. PubMed ID: 16637040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential effects of levodopa and subthalamic nucleus deep brain stimulation on bradykinesia in Parkinson's disease.
    Timmermann L; Braun M; Groiss S; Wojtecki L; Ostrowski S; Krause H; Pollok B; Südmeyer M; Ploner M; Gross J; Maarouf M; Voges J; Sturm V; Schnitzler A
    Mov Disord; 2008 Jan; 23(2):218-27. PubMed ID: 18044706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Targeting methods in deep brain stimulation for Parkinson's disease].
    Toda H
    No Shinkei Geka; 2011 Jan; 39(1):25-35. PubMed ID: 21270476
    [No Abstract]   [Full Text] [Related]  

  • 17. Subthalamic nucleus stimulation in Parkinson's disease patients intolerant to levodopa.
    Lyons KE; Davis JT; Pahwa R
    Stereotact Funct Neurosurg; 2007; 85(4):169-74. PubMed ID: 17259749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Stereotaxic neurosurgery for treatment of Parkinson disease].
    Speelman JD; Esselink RA; Schuurman PR; de Bie RM; Bosch DA
    Ned Tijdschr Geneeskd; 2001 May; 145(18):853-8. PubMed ID: 11379394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The paradoxical role of dopamine after subthalamic nucleus deep brain stimulation--downstream is upstream in a circuit diagram. Comment on "Does dopamine still have a leading role in advanced Parkinson's disease after subthalamic stimulation?" (Stereotact Funct Neurosurg 2008;86: 184-186).
    Gross RE
    Stereotact Funct Neurosurg; 2008; 86(3):189-90. PubMed ID: 18477863
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of subthalamic nucleus deep brain stimulation on axial motor control and protective arm responses in Parkinson's disease.
    Visser JE; Allum JH; Carpenter MG; Esselink RA; Limousin-Dowsey P; Honegger F; Borm GF; Bloem BR
    Neuroscience; 2008 Dec; 157(4):798-812. PubMed ID: 18952153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.